MERCK KGAA O.N./ DE0006599905 /
6/27/2022 9:55:06 PM | Chg. -0.750 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
164.150EUR | -0.45% | 798 Turnover: 134,179.900 |
-Bid Size: - | -Ask Size: - | 21.34 bill.EUR | 1.12% | 23.49 |
GlobeNewswire
2/10
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Cl...
GlobeNewswire
1/11
Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
GlobeNewswire
1/10
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal ...
GlobeNewswire
1/5
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in ...
GlobeNewswire
11/18/2021
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development U...